Red X iconGreen tick iconYellow tick icon
Skip to main content Skip to side navigation

Sean MacPhersonSenior Lecturer
Haematologist

BSc(Hons), MB ChB(Hons), MRCP(Glasgow), FRCPath, PG Cert Med Ed

Email sean.macpherson@otago.ac.nz

Publications

Lee, Z. J. O., Turner, G. D. H., Chan, H. L. E., MacPherson, S. A., Chang, K. T. E., Yong, M. H., … Ng, S.-B. (2026). SMARCB1/INI1-deficient peripheral T-cell lymphoma: Two cases expanding the spectrum of an emerging entity and a review of the literature. Virchows Archiv. Advance online publication. doi: 10.1007/s00428-026-04674-0 Journal - Research Other

Dobson, L. J., Hock, B. D., Drabble, A. H. T., Goddard, L., McKenzie, J. L., MacPherson, S. A., & McLellan, A. D. (2026). Enhanced Fc and complement activity of Fc-modified avelumab boosts anti-tumor activity but promotes NK cell fratricide. Clinical & Translational Immunology, 15, e70098. doi: 10.1002/cti2.70098 Journal - Research Article

Hock, B. D., Goddard, L., Dobson, L. J., MacPherson, S. A., O'Donnell, J. L., McKenzie, J. L., & McLellan, A. D. (2025). Impact of rheumatoid factors on the function of therapeutic monoclonals specific for PD-1/PD-L1. Cancer Immunology, Immunotherapy, 74, 216. doi: 10.1007/s00262-025-04078-0 Journal - Research Article

Hock, B. D., Goddard, L., MacPherson, S. A., Strother, M., Gibbs, D., Pearson, J. F., & McKenzie, J. L. (2023). Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab. PLoS ONE, 18(9), e0290793. doi: 10.1371/journal.pone.0290793 Journal - Research Article

Carr, A. C., Vlasiuk, E., Zawari, M., Meijer, N., Lauren, C., MacPherson, S., Williman, J., & Chambers, S. T. (2022). Supplementation with oral vitamin C prior to and during myeloablative chemotherapy and autologous haematopoietic stem cell transplantation: A pilot study. Antioxidants, 11(10), 1949. doi: 10.3390/antiox11101949 Journal - Research Article

Back to top